Clinical Trial Update: Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

This document reports the completion and results posting of a Phase 2 study evaluating aflibercept combined with modified FOLFOX6 as first-line treatment for me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• Zaltrap (ramucirumab)

Snippet

Sponsor: Sanofi | Conditions: Colorectal Neoplasms, Neoplasm Metastasis | Phase 2 | Status: COMPLETED | Results posted: 2013-06-25